Content-Length: 298500 | pFad | http://www.nature.com/articles/s41569-024-01112-z

ma=86400 Targeting macrophage–fibroblast interactions in the failing heart | Nature Reviews Cardiology
Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

Cardioimmunology

Targeting macrophage–fibroblast interactions in the failing heart

Macrophage–fibroblast interactions have a central role in cardiac fibrosis. In response to left ventricular pressure overload, CCR2+ cardiac macrophages acquire a fibrogenic phenotype, secreting IL-1β and promoting the activation of a FAP+ POSTN+ fibroblast subpopulation through the transcription factor MEOX1. Macrophage-derived fibroblast-activating cytokines (such as IL-1β), growth factors and matricellular proteins contribute to the pathogenesis of heart failure.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Fig. 1: Macrophage–fibroblast interactions in the failing heart.

References

  1. Frangogiannis, N. G. Cardiac fibrosis. Cardiovasc. Res. 117, 1450–1488 (2021).

    Article  CAS  PubMed  Google Scholar 

  2. Amrute, J. M. et al. Targeting immune-fibroblast cell communication in heart failure. Nature 635, 423–433 (2024).

    Article  CAS  PubMed  Google Scholar 

  3. Alexanian, M. et al. Chromatin remodelling drives immune cell–fibroblast communication in heart failure. Nature 635, 434–443 (2024).

    Article  CAS  PubMed  Google Scholar 

  4. Alexanian, M. et al. A transcriptional switch governs fibroblast activation in heart disease. Nature 595, 438–443 (2021).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Zhou, X. et al. Circuit design features of a stable two-cell system. Cell 172, 744–757 e717 (2018).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. van Amerongen, M. J., Harmsen, M. C., van Rooijen, N., Petersen, A. H. & van Luyn, M. J. Macrophage depletion impairs wound healing and increases left ventricular remodeling after myocardial injury in mice. Am. J. Pathol. 170, 818–829 (2007).

    Article  PubMed  PubMed Central  Google Scholar 

  7. Frangogiannis, N. G. et al. Critical role of monocyte chemoattractant protein-1/CC chemokine ligand 2 in the pathogenesis of ischemic cardiomyopathy. Circulation 115, 584–592 (2007).

    Article  CAS  PubMed  Google Scholar 

  8. Anzai, A. et al. The infarcted myocardium solicits GM-CSF for the detrimental oversupply of inflammatory leukocytes. J. Exp. Med. 214, 3293–3310 (2017).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Humeres, C. et al. Fibroblast Smad7 induction protects the remodeling pressure-overloaded heart. Circ. Res. 135, 453–469 (2024).

    Article  CAS  PubMed  Google Scholar 

  10. Patrick, R. et al. Integration mapping of cardiac fibroblast single-cell transcriptomes elucidates cellular principles of fibrosis in diverse pathologies. Sci. Adv. 10, eadk8501 (2024).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Saxena, A. et al. IL-1 induces proinflammatory leukocyte infiltration and regulates fibroblast phenotype in the infarcted myocardium. J. Immunol. 191, 4838–4848 (2013).

    Article  CAS  PubMed  Google Scholar 

  12. Bujak, M. et al. Interleukin-1 receptor type I signaling critically regulates infarct healing and cardiac remodeling. Am. J. Pathol. 173, 57–67 (2008).

    Article  PubMed  PubMed Central  Google Scholar 

  13. Bageghni, S. A. et al. Fibroblast-specific deletion of interleukin-1 receptor-1 reduces adverse cardiac remodeling following myocardial infarction. JCI Insight 5, e125074 (2019).

    Article  PubMed  Google Scholar 

  14. Li, R. et al. Macrophages in the infarcted heart acquire a fibrogenic phenotype, expressing matricellular proteins, but do not undergo fibroblast conversion. J. Mol. Cell. Cardiol. 196, 152–167 (2024).

    Article  CAS  PubMed  Google Scholar 

  15. Everett, B. M. et al. Anti-inflammatory therapy with canakinumab for the prevention of hospitalization for heart failure. Circulation 139, 1289–1299 (2019).

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

The author’s laboratory is supported by NIH grants R01 HL76246, R01 HL85440 and R01 HL149407, and by the US Department of Defense grant PR211352.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Nikolaos G. Frangogiannis.

Ethics declarations

Competing interests

The author declares no competing interests.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Frangogiannis, N.G. Targeting macrophage–fibroblast interactions in the failing heart. Nat Rev Cardiol (2024). https://doi.org/10.1038/s41569-024-01112-z

Download citation

  • Published:

  • DOI: https://doi.org/10.1038/s41569-024-01112-z

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing








ApplySandwichStrip

pFad - (p)hone/(F)rame/(a)nonymizer/(d)eclutterfier!      Saves Data!


--- a PPN by Garber Painting Akron. With Image Size Reduction included!

Fetched URL: http://www.nature.com/articles/s41569-024-01112-z

Alternative Proxies:

Alternative Proxy

pFad Proxy

pFad v3 Proxy

pFad v4 Proxy